Interleukin-7, interleukin-12, and GM-CSF gene transfer in patients with metastatic melanoma.
Schadendorf
D
D
Virchow-Klinik, Dermatologie, Humboldt Universität Berlin, Germany.
Czarnetzki
B M
BM
Wittig
B
B
D002986:Clinical Trials as Topic / Q000379:methods*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods; D005434:Flow Cytometry; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000096:biosynthesis / Q000235:genetics*; D006801:Humans; D018664:Interleukin-12 / Q000096:biosynthesis / Q000235:genetics*; D015851:Interleukin-7 / Q000096:biosynthesis / Q000235:genetics*; D015979:Killer Cells, Lymphokine-Activated; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D010865:Pilot Projects; D013601:T-Lymphocytes / Q000276:immunology; D014162:Transfection / Q000379:methods*
D015851:Interleukin-7; D018664:Interleukin-12; D016178:Granulocyte-Macrophage Colony-Stimulating Factor